Day: March 4, 2017

The AmBisome Patient

That’s what they sometimes call me at the infusion center. AmBisome is a trade name for amphotericin. According to Wikipedia:”Amphotericin B is well known for its severe and potentially lethal side effects… Intravenously administered amphotericin B in therapeutic doses has also been associated with multiple organ damage. Kidney damage is a frequently reported side effect, and can be severe and/or irreversible.” The AmBisome patient is the one who requires three-and-a-half hours of treatment every day, except when her […]

Read more